Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells

British Journal of Cancer

Volumn 84, Issue 5, 2001, Pages 691-696

  Ronen, S M ^a   Jackson, L E ^a   Beloueche, M ^a   Leach, M O ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

31P spectroscopy; Magnetic resonance; NIH 3T3; Phosphocholine; Ras

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHORYLCHOLINE; RAS PROTEIN; SIMVASTATIN; TIPIFARNIB;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; GENE MUTATION; GENETIC TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE H RAS; PHOSPHOLIPID METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN CONTENT;

3T3 CELLS; ANIMALS; BENZOQUINONES; CELL DIVISION; CELL LINE, TRANSFORMED; ENZYME INHIBITORS; GENES, RAS; LACTAMS, MACROCYCLIC; MAGNETIC RESONANCE SPECTROSCOPY; MAP KINASE SIGNALING SYSTEM; MICE; MUTATION; NUCLEOTIDES; PHOSPHORYLCHOLINE; PROTO-ONCOGENE PROTEINS P21(RAS); QUINOLONES; RIFABUTIN; SIMVASTATIN; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 0035793795     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1663     Document Type: Article

References (28)

1. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells
2. Immortalization and transformation are associated with specific alternations in choline metabolism
3. Evidence for a bifurcation of the mitogenic signaling pathway activated by ras and phosphatidylcholine-hydrolyzing phsopholipase C
4. Clinical evaluation of biologically targeted drugs: Obstacles and opportunities
5. Activation of D phospholipase by serum stimulation and ras-induced transformation in NIH3T3 cells
6. Multiple ras effector pathways contribute to G1 cell cycle progression
7. Induction of cytosolic phospholipase A2 by oncogenic Ras in human non-small cell lung cancer
8. Mutations of ras genes in human tumours
9. Diacylglycerol production in Xenopus laevis oocytes after microinjection of p21 ras proteins is a consequence of activation of phosphatidylcholine metabolism
10. Novel source of 1,2-diacylglycerol elevated in cells transformed by Ha-ras oncogene
11. Inhibition of isoprenoid biosynthesis and the post-translational modification of pro-p21
12. cP1A2 is phosphorylated and activated by MAP kinase
13. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells
14. Kinetic evidence of a rapid activation of phosphatidylcholine hydrolysis by Ki-ras oncogene. Possible involvement in late steps of mitogenic cascade
15. Studies of human tumours by MRS: A review
16. Tumour phospholipid metabolism
17. Detection of phosphatidylcholine-specific phospholipase C in NIH-3T3 fibroblasts and their H-ras transformants: NMR and immunochemical studies
18. Stimulation of phosphatidylcholine hydrolysis, diacylglycerol release and arachidonic acid production by oncogenic ras is a consequence of protein kinase C activation
19. Early increase in choline kinase activity upon induction of the H-ras oncogene in mourse fibroblast cell lines
20. Lipid metabolism in large T47D human breast cancer spheroids: 31P- and 13C-NMR studies of choline and ethanolamine uptake
21. Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosis
22. The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin
23. The phosphocholine and glycerophosphocholine content of an oestrogen-sensitive rat mammary tumour correlates strongly with growth rate
24. Altered phosphatidylcholine metabolism in C3H10T cells transfected with the Harvey-ras oncogene
25. Variations in energy and phosphlipid metabolism in normal and cancer human mammary epithelial cells
26. Simultaneous extraction of cellular lipids and water-soluble metabolities: Evaluation by NMR spectroscopy
27. Evidence for phosphorylation of CTP: Phosphocholine cytidyltrasferase by multiple proline directed protein kinases
28. Phase I and Pharmacokinetic Study of Farnesyl Protein Transferase Inhibitor R115777 in Advanced Cancer